Journal article
Two novel germline KRAS mutations: Expanding the molecular and clinical phenotype
Z Stark, G Gillessen-Kaesbach, MM Ryan, IC Cirstea, L Gremer, MR Ahmadian, R Savarirayan, M Zenker
Clinical Genetics | Published : 2012
Abstract
Noonan and Cardio-facio-cutaneous (CFC) syndromes are characterized by typical dysmorphic features, cardiac defects, short stature, variable ectodermal anomalies, and intellectual disability. Both belong to the Ras/mitogen-activated protein kinase pathway group of disorders and clinical features overlap other related conditions, notably LEOPARD and Costello syndromes. KRAS mutations account for about 2% of reported Noonan and <5% of reported CFC cases. The mutation spectrum includes recurrent missense changes clustering in particular domains of the KRAS protein and conferring gain-of-function. We report three patients from two unrelated families with novel missense KRAS mutations, p.K147E an..
View full abstractGrants
Funding Acknowledgements
We thank the families for their participation in the research. This work was supported by grants from the European Research Area Network for research programmes on rare diseases (E-Rare) 2009 to M. Z. and M. R. A. (European Network on Noonan Syndrome and Related Disorders).